Acute myocardial infarction is now considered more treatable than ever. However, despite optimized reperfusion, modern pharmacotherapies and improved care systems, one risk remains that is underestimated in many clinical procedures: the development of new heart failure after surviving an infarction. A recent analysis by a large US healthcare system shows that post-infarction heart failure occurs more frequently than a new myocardial infarction – and significantly affects the prognosis of those affected.
You May Also Like
- Treatment resistant depression
Esketamine nasal spray as monotherapy? New for treatment-resistant depression
- Analysis of SNVCS data from the period 2005-2022
TBE vaccination for children and adolescents in Switzerland
- Tuberculosis
Detecting diabetes in TB patients early and efficiently
- Trichophyton indotineae
Terbinafine-resistant dermatophytoses are on the rise in Central Europe
- Peristomal skin health
Focus on preventive care options
- Disease-modifying therapies for ATTR-CM
TTR stabilizers, gene silencing and gene scissors: where do we stand?
- Proteins in wound healing
Do special amino acids lead to success?
- HER2+ early breast cancer